vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Rollins, Inc. (ROL). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $906.4M, roughly 1.1× Rollins, Inc.). Rollins, Inc. runs the higher net margin — 11.9% vs -1.1%, a 13.0% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 10.2%). Rollins, Inc. produced more free cash flow last quarter ($111.2M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 0.8%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Rollins, Inc. is a North American pest control company serving residential and commercial clients. Operating globally through its wholly owned subsidiaries, Orkin, Inc., PCO Services, HomeTeam Pest Defense, Western Pest Services, Industrial Fumigant Company, TruTech, Critter Control, Crane, Waltham, OPC Services, PermaTreat, Northwest Exterminating, McCall Service and Clark Pest Control, as well UK subsidiaries Integrated Pest Management Limited, Safeguard Pest Control, NBC Environment, Europ...

ALHC vs ROL — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.1× larger
ALHC
$1.0B
$906.4M
ROL
Growing faster (revenue YoY)
ALHC
ALHC
+34.2% gap
ALHC
44.4%
10.2%
ROL
Higher net margin
ROL
ROL
13.0% more per $
ROL
11.9%
-1.1%
ALHC
More free cash flow
ROL
ROL
$166.6M more FCF
ROL
$111.2M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
0.8%
ROL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALHC
ALHC
ROL
ROL
Revenue
$1.0B
$906.4M
Net Profit
$-11.0M
$107.8M
Gross Margin
Operating Margin
-1.0%
16.1%
Net Margin
-1.1%
11.9%
Revenue YoY
44.4%
10.2%
Net Profit YoY
64.6%
2.5%
EPS (diluted)
$-0.04
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
ROL
ROL
Q1 26
$906.4M
Q4 25
$1.0B
$912.9M
Q3 25
$993.7M
$1.0B
Q2 25
$1.0B
$999.5M
Q1 25
$926.9M
$822.5M
Q4 24
$701.2M
$832.2M
Q3 24
$692.4M
$916.3M
Q2 24
$681.3M
$891.9M
Net Profit
ALHC
ALHC
ROL
ROL
Q1 26
$107.8M
Q4 25
$-11.0M
$116.4M
Q3 25
$3.7M
$163.5M
Q2 25
$15.7M
$141.5M
Q1 25
$-9.1M
$105.2M
Q4 24
$-31.1M
$105.7M
Q3 24
$-26.4M
$136.9M
Q2 24
$-24.0M
$129.4M
Operating Margin
ALHC
ALHC
ROL
ROL
Q1 26
16.1%
Q4 25
-1.0%
17.5%
Q3 25
0.8%
21.9%
Q2 25
2.2%
19.8%
Q1 25
-0.6%
17.3%
Q4 24
-3.2%
18.1%
Q3 24
-2.8%
20.9%
Q2 24
-2.7%
20.4%
Net Margin
ALHC
ALHC
ROL
ROL
Q1 26
11.9%
Q4 25
-1.1%
12.8%
Q3 25
0.4%
15.9%
Q2 25
1.5%
14.2%
Q1 25
-1.0%
12.8%
Q4 24
-4.4%
12.7%
Q3 24
-3.8%
14.9%
Q2 24
-3.5%
14.5%
EPS (diluted)
ALHC
ALHC
ROL
ROL
Q1 26
$0.22
Q4 25
$-0.04
$0.24
Q3 25
$0.02
$0.34
Q2 25
$0.07
$0.29
Q1 25
$-0.05
$0.22
Q4 24
$-0.15
$0.22
Q3 24
$-0.14
$0.28
Q2 24
$-0.13
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
ROL
ROL
Cash + ST InvestmentsLiquidity on hand
$604.2M
$116.5M
Total DebtLower is stronger
$323.2M
$650.6M
Stockholders' EquityBook value
$179.3M
$1.4B
Total Assets
$1.1B
$3.2B
Debt / EquityLower = less leverage
1.80×
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
ROL
ROL
Q1 26
$116.5M
Q4 25
$604.2M
$100.0M
Q3 25
$644.1M
$127.4M
Q2 25
$503.8M
$123.0M
Q1 25
$479.5M
$201.2M
Q4 24
$470.6M
$89.6M
Q3 24
$381.0M
$95.3M
Q2 24
$363.7M
$106.7M
Total Debt
ALHC
ALHC
ROL
ROL
Q1 26
$650.6M
Q4 25
$323.2M
$486.1M
Q3 25
$322.7M
$485.7M
Q2 25
$322.3M
$485.3M
Q1 25
$321.9M
$485.5M
Q4 24
$321.4M
$395.3M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
ROL
ROL
Q1 26
$1.4B
Q4 25
$179.3M
$1.4B
Q3 25
$161.9M
$1.5B
Q2 25
$141.0M
$1.4B
Q1 25
$108.1M
$1.4B
Q4 24
$99.9M
$1.3B
Q3 24
$114.5M
$1.3B
Q2 24
$123.7M
$1.2B
Total Assets
ALHC
ALHC
ROL
ROL
Q1 26
$3.2B
Q4 25
$1.1B
$3.1B
Q3 25
$1.1B
$3.2B
Q2 25
$1.0B
$3.2B
Q1 25
$895.6M
$2.9B
Q4 24
$782.1M
$2.8B
Q3 24
$692.3M
$2.8B
Q2 24
$716.3M
$2.8B
Debt / Equity
ALHC
ALHC
ROL
ROL
Q1 26
0.47×
Q4 25
1.80×
0.35×
Q3 25
1.99×
0.32×
Q2 25
2.29×
0.34×
Q1 25
2.98×
0.36×
Q4 24
3.22×
0.30×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
ROL
ROL
Operating Cash FlowLast quarter
$-50.4M
$118.4M
Free Cash FlowOCF − Capex
$-55.4M
$111.2M
FCF MarginFCF / Revenue
-5.5%
12.3%
Capex IntensityCapex / Revenue
0.5%
0.8%
Cash ConversionOCF / Net Profit
1.10×
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$621.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
ROL
ROL
Q1 26
$118.4M
Q4 25
$-50.4M
$164.7M
Q3 25
$144.6M
$191.3M
Q2 25
$29.1M
$175.1M
Q1 25
$16.6M
$146.9M
Q4 24
$-8.7M
$188.2M
Q3 24
$26.2M
$146.9M
Q2 24
$23.5M
$145.1M
Free Cash Flow
ALHC
ALHC
ROL
ROL
Q1 26
$111.2M
Q4 25
$-55.4M
$159.0M
Q3 25
$139.1M
$182.8M
Q2 25
$21.1M
$168.0M
Q1 25
$8.4M
$140.1M
Q4 24
$-18.0M
$184.0M
Q3 24
$16.9M
$139.4M
Q2 24
$11.8M
$136.4M
FCF Margin
ALHC
ALHC
ROL
ROL
Q1 26
12.3%
Q4 25
-5.5%
17.4%
Q3 25
14.0%
17.8%
Q2 25
2.1%
16.8%
Q1 25
0.9%
17.0%
Q4 24
-2.6%
22.1%
Q3 24
2.4%
15.2%
Q2 24
1.7%
15.3%
Capex Intensity
ALHC
ALHC
ROL
ROL
Q1 26
0.8%
Q4 25
0.5%
0.6%
Q3 25
0.6%
0.8%
Q2 25
0.8%
0.7%
Q1 25
0.9%
0.8%
Q4 24
1.3%
0.5%
Q3 24
1.3%
0.8%
Q2 24
1.7%
1.0%
Cash Conversion
ALHC
ALHC
ROL
ROL
Q1 26
1.10×
Q4 25
1.41×
Q3 25
38.77×
1.17×
Q2 25
1.86×
1.24×
Q1 25
1.40×
Q4 24
1.78×
Q3 24
1.07×
Q2 24
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons